Diabetic patients with COVID-19: low antibody levels linked to worse outcomes Post author: Post published: October 30, 2023 Post category:uncategorized The role of anti-SARS-CoV-2 antibody levels on COVID-19 outcomes in patients with T2D. You Might Also Like Study reveals gaps in contraception access despite 12-month supply policies September 19, 2024 Chronic inflammation leaves epigenetic scars that increase future cancer risk March 25, 2026 Study links COVID-19 to increased risk of acute kidney disorders September 30, 2024